![Gayle H. Diamond, MD](/sites/default/files/styles/crop_and_center_300x375/public/providers-new-diamond-gayle.jpg?itok=EHgpX889)
Gayle H. Diamond, MD
Areas of expertise: General pediatric gastroenterology, Diagnosis and management of gastrointestinal diseases in all pediatric age groups
About Gayle H. Diamond, MD
Titles
Attending Physician
Associate Professor of Clinical Pediatrics (Gastroenterology, Hepatology and Nutrition), Perelman School of Medicine at the University of Pennsylvania
Certifications
Pediatric Gastroenterology – American Board of Pediatrics
Pediatrics – American Board of Pediatrics
Awards and Honors
2016-2018, 2021, Division of GI, Hepatology, and Nutrition, Fellows Teaching Award Honor Roll
2006-2008, NIH Loan Repayment Program
2006, Travel award for AGA fellows’ training conference
Leadership and Memberships
Memberships in Professional Organizations
International
2006-present, North American Society for Pediatric Gastroenterology, Hepatology and Nutrition
- 2020-present, Nutrition Committee
Editorial and Academic Positions
Academic and Institutional Committees
2019-present, Fellowship Clinical Competency Committee
Education & training
Medical Degree
MD - Temple University School of Medicine, Philadelphia, PA
Internship
Pediatrics - Emory University, Atlanta, GA
Residency
Pediatrics - Emory University, Atlanta, GA
Fellowship
Pediatric Gastroenterology - Emory University, Atlanta, GA
Publications
Publications
2002
Lewis MI, Horvitz GD, Clemmons DR, Fournier M: Role of IGF-I and IGF-binding proteins within diaphragm muscle in modulating the effects of nandrolone. American Journal of Physiology. Endocrinology and Metabolism 282(2): E483-90, 2002.
1999
Clemmons DR, Horvitz G, Engleman W, Nichols T, Moralez A, Nickols GA: Synthetic alphaVbeta3 antagonists inhibit insulin-like growth factor-I-stimulated smooth muscle cell migration and replication. Endocrinology 140(10): 4616-21, 1999.
1998
Rees C, Clemmons DR, Horvitz GD, Clarke JB, Busby, WH: A protease-resistant form of insulin-like growth factor (IGF) binding protein 4 inhibits IGF-1 actions. Endocrinology 139(10): 4182-8, 1998.
1997
Imai Y, Busby WH, Smith CE, Clarke JB, Garmong AJ, Horvitz GD, Rees CR, Clemmons DR: Protease-resistant form of insulin-like growth factor-binding protein 5 is an inhibitor of insulin-like growth factor-I actions of porcine smooth muscle cells in culture. Journal of Clinical Investigation 100(10): 2596-2605, 1997.